Showing results (1-10 of 23) with videos related to
Sort By:
Pageof 3
Cancer Journal (Sudbury, Mass.)|May 8, 2004
Novel systemic therapy options for hepatocellular carcinomaMike Cusnir, Yehuda Z PattJournal of Clinical Gastroenterology|August 23, 2002
Rising prevalence of hepatitis C virus infection among patients recently diagnosed with hepatocellular carcinoma in the United StatesManal M Hassan, Adam Frome, Yehuda Z Patt, et al.Liver Cancer|May 29, 2015
Treatment of hepatocellular carcinoma in the community: disparities in standard therapyLinda C Harlan, Helen M Parsons, Charles L Wiggins, et al.The Oncologist|May 25, 2012
A randomized, phase II trial of standard triweekly compared with dose-dense biweekly capecitabine plus oxaliplatin plus bevacizumab as first-line treatment for metastatic colorectal cancer: XELOX-A-DVS (dense versus standard)Herbert Hurwitz, Edith P Mitchell, Thomas Cartwright, et al.Hepatology (Baltimore, Md.)|April 30, 2003
Recombinant human interleukin-11 improves thrombocytopenia in patients with cirrhosisReem Ghalib, Cheryl Levine, Manal Hassan, et al.Journal of Cancer Research and Clinical Oncology|May 28, 2008
A phase I/II trial of TAC-101, an oral synthetic retinoid, in patients with advanced hepatocellular carcinomaKimberly B Higginbotham, Richard Lozano, Thomas Brown, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2003
Phase II trial of systemic continuous fluorouracil and subcutaneous recombinant interferon Alfa-2b for treatment of hepatocellular carcinomaYehuda Z Patt, Manal M Hassan, Richard D Lozano, et al.Hepatology (Baltimore, Md.)|October 24, 2002
Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitusManal M Hassan, Lu-Yu Hwang, Chiq J Hatten, et al.The American Journal of Gastroenterology|February 28, 2007
Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control studyYasser H Shaib, Hashem B El-Serag, Ajay K Nooka, et al.Cancer|January 22, 2005
Thalidomide in the treatment of patients with hepatocellular carcinoma: a phase II trialYehuda Z Patt, Manal M Hassan, Richard D Lozano, et al.Pageof 3